

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 9.89104434 |
| 2 | ATP synthesis coupled proton transport (GO:0015986) | 9.89104434 |
| 3 | * mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 9.48370416 |
| 4 | * respiratory electron transport chain (GO:0022904) | 8.81930637 |
| 5 | * electron transport chain (GO:0022900) | 8.59696767 |
| 6 | oxidative phosphorylation (GO:0006119) | 5.90274450 |
| 7 | ATP biosynthetic process (GO:0006754) | 5.65956832 |
| 8 | tricarboxylic acid cycle (GO:0006099) | 5.55834998 |
| 9 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 5.23391888 |
| 10 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 5.15875072 |
| 11 | protein complex biogenesis (GO:0070271) | 5.09939088 |
| 12 | hydrogen ion transmembrane transport (GO:1902600) | 5.07511114 |
| 13 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.98092172 |
| 14 | NADH dehydrogenase complex assembly (GO:0010257) | 4.98092172 |
| 15 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.98092172 |
| 16 | inner mitochondrial membrane organization (GO:0007007) | 4.88488436 |
| 17 | chaperone-mediated protein transport (GO:0072321) | 4.79359393 |
| 18 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.70652063 |
| 19 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.69198005 |
| 20 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 4.57679814 |
| 21 | proton transport (GO:0015992) | 4.45297233 |
| 22 | hydrogen transport (GO:0006818) | 4.38806127 |
| 23 | aerobic respiration (GO:0009060) | 4.36701381 |
| 24 | NADH metabolic process (GO:0006734) | 4.35200820 |
| 25 | regulation of mitochondrial translation (GO:0070129) | 4.03426575 |
| 26 | succinate metabolic process (GO:0006105) | 4.01836265 |
| 27 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.99602176 |
| 28 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.98404374 |
| 29 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.94474448 |
| 30 | protein neddylation (GO:0045116) | 3.94397507 |
| 31 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.86078457 |
| 32 | regulation of oxidative phosphorylation (GO:0002082) | 3.79914851 |
| 33 | ubiquinone biosynthetic process (GO:0006744) | 3.76050045 |
| 34 | quinone biosynthetic process (GO:1901663) | 3.76050045 |
| 35 | GTP biosynthetic process (GO:0006183) | 3.74414581 |
| 36 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.74150689 |
| 37 | regulation of cell communication by electrical coupling (GO:0010649) | 3.73515142 |
| 38 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.70610750 |
| 39 | cotranslational protein targeting to membrane (GO:0006613) | 3.70310572 |
| 40 | muscle filament sliding (GO:0030049) | 3.70298143 |
| 41 | actin-myosin filament sliding (GO:0033275) | 3.70298143 |
| 42 | sarcomere organization (GO:0045214) | 3.69761795 |
| 43 | ribosomal small subunit assembly (GO:0000028) | 3.69253409 |
| 44 | viral transcription (GO:0019083) | 3.67386566 |
| 45 | regulation of coenzyme metabolic process (GO:0051196) | 3.66194316 |
| 46 | regulation of cofactor metabolic process (GO:0051193) | 3.66194316 |
| 47 | heart process (GO:0003015) | 3.65090822 |
| 48 | heart contraction (GO:0060047) | 3.65090822 |
| 49 | protein targeting to ER (GO:0045047) | 3.63939075 |
| 50 | translational termination (GO:0006415) | 3.61530544 |
| 51 | mitochondrial transport (GO:0006839) | 3.60850317 |
| 52 | cellular respiration (GO:0045333) | 3.55056447 |
| 53 | regulation of relaxation of muscle (GO:1901077) | 3.53700273 |
| 54 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.52686645 |
| 55 | protein localization to endoplasmic reticulum (GO:0070972) | 3.49523574 |
| 56 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.46837248 |
| 57 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.46837248 |
| 58 | * generation of precursor metabolites and energy (GO:0006091) | 3.46418708 |
| 59 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.44934517 |
| 60 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.44934517 |
| 61 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.42109810 |
| 62 | regulation of cellular respiration (GO:0043457) | 3.41475329 |
| 63 | ubiquinone metabolic process (GO:0006743) | 3.38905304 |
| 64 | platelet dense granule organization (GO:0060155) | 3.34288234 |
| 65 | cardiac muscle contraction (GO:0060048) | 3.30232167 |
| 66 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.24842828 |
| 67 | protein targeting to mitochondrion (GO:0006626) | 3.22954902 |
| 68 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.20029757 |
| 69 | cardiac myofibril assembly (GO:0055003) | 3.19589116 |
| 70 | establishment of protein localization to mitochondrion (GO:0072655) | 3.19248391 |
| 71 | cytochrome complex assembly (GO:0017004) | 3.18741657 |
| 72 | DNA damage response, detection of DNA damage (GO:0042769) | 3.18139145 |
| 73 | regulation of helicase activity (GO:0051095) | 3.17551140 |
| 74 | respiratory chain complex IV assembly (GO:0008535) | 3.16690340 |
| 75 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.16636979 |
| 76 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.14134210 |
| 77 | ribosomal large subunit biogenesis (GO:0042273) | 3.13159107 |
| 78 | protein localization to mitochondrion (GO:0070585) | 3.10378150 |
| 79 | myofibril assembly (GO:0030239) | 3.08475087 |
| 80 | translational elongation (GO:0006414) | 3.08218063 |
| 81 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.07184563 |
| 82 | translation (GO:0006412) | 3.06867326 |
| 83 | oxaloacetate metabolic process (GO:0006107) | 3.06695390 |
| 84 | regulation of skeletal muscle contraction (GO:0014819) | 3.02845371 |
| 85 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.01714499 |
| 86 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.01714499 |
| 87 | UTP biosynthetic process (GO:0006228) | 3.01414204 |
| 88 | actin-mediated cell contraction (GO:0070252) | 3.00919181 |
| 89 | regulation of actin filament-based movement (GO:1903115) | 2.99748227 |
| 90 | purine ribonucleoside biosynthetic process (GO:0046129) | 2.99492422 |
| 91 | purine nucleoside biosynthetic process (GO:0042451) | 2.99492422 |
| 92 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.98870947 |
| 93 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.96356723 |
| 94 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.95205208 |
| 95 | cullin deneddylation (GO:0010388) | 2.95186633 |
| 96 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.93585770 |
| 97 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.91107856 |
| 98 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.87169600 |
| 99 | substantia nigra development (GO:0021762) | 2.84568475 |
| 100 | translational initiation (GO:0006413) | 2.84037524 |
| 101 | negative regulation of ligase activity (GO:0051352) | 2.81565091 |
| 102 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.81565091 |
| 103 | branched-chain amino acid catabolic process (GO:0009083) | 2.81175964 |
| 104 | proteasome assembly (GO:0043248) | 2.80235474 |
| 105 | UTP metabolic process (GO:0046051) | 2.79310822 |
| 106 | nucleoside diphosphate phosphorylation (GO:0006165) | 2.79074616 |
| 107 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.79067105 |
| 108 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.78026347 |
| 109 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.77988777 |
| 110 | regulation of sarcomere organization (GO:0060297) | 2.76764108 |
| 111 | cellular protein complex disassembly (GO:0043624) | 2.76664833 |
| 112 | viral life cycle (GO:0019058) | 2.76319548 |
| 113 | aldehyde catabolic process (GO:0046185) | 2.75371957 |
| 114 | cellular ketone body metabolic process (GO:0046950) | 2.74961189 |
| 115 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.74413374 |
| 116 | regulation of sulfur metabolic process (GO:0042762) | 2.73803513 |
| 117 | ribonucleoside monophosphate biosynthetic process (GO:0009156) | 2.73778316 |
| 118 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.71952151 |
| 119 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.71443907 |
| 120 | striated muscle contraction (GO:0006941) | 2.70277381 |
| 121 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.69554299 |
| 122 | protein deneddylation (GO:0000338) | 2.69385471 |
| 123 | protein-cofactor linkage (GO:0018065) | 2.68537341 |
| 124 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.64065465 |
| 125 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.64065465 |
| 126 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.64065465 |
| 127 | intracellular protein transmembrane import (GO:0044743) | 2.62701754 |
| 128 | signal peptide processing (GO:0006465) | 2.62666513 |
| 129 | termination of RNA polymerase III transcription (GO:0006386) | 2.62543969 |
| 130 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.62543969 |
| 131 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.62296371 |
| 132 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.62296371 |
| 133 | CENP-A containing nucleosome assembly (GO:0034080) | 2.61925204 |
| 134 | dopamine transport (GO:0015872) | 2.61190892 |
| 135 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.61062902 |
| 136 | quinone metabolic process (GO:1901661) | 2.60985005 |
| 137 | regulation of striated muscle contraction (GO:0006942) | 2.60559581 |
| 138 | negative regulation of heart rate (GO:0010459) | 2.60138290 |
| 139 | response to epinephrine (GO:0071871) | 2.58359982 |
| 140 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.58184178 |
| 141 | aspartate family amino acid catabolic process (GO:0009068) | 2.57698114 |
| 142 | cellular component biogenesis (GO:0044085) | 2.54043787 |
| 143 | intraciliary transport (GO:0042073) | 2.52849814 |
| 144 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.51293765 |
| 145 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.51293765 |
| 146 | glutathione derivative biosynthetic process (GO:1901687) | 2.51218297 |
| 147 | glutathione derivative metabolic process (GO:1901685) | 2.51218297 |
| 148 | chromatin remodeling at centromere (GO:0031055) | 2.50780950 |
| 149 | resolution of meiotic recombination intermediates (GO:0000712) | 2.50416380 |
| 150 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.49509139 |
| 151 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 10.4865937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.04590737 |
| 2 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.80517069 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.69850195 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.16068865 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.07911230 |
| 6 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.02357411 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.96837410 |
| 8 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.96643956 |
| 9 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.72492186 |
| 10 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.57890819 |
| 11 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.48542709 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.40998060 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.36204175 |
| 14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.30265860 |
| 15 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.26635791 |
| 16 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.24715440 |
| 17 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.18878082 |
| 18 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.15877122 |
| 19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.14756773 |
| 20 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.08222888 |
| 21 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.06332064 |
| 22 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.95891090 |
| 23 | EWS_26573619_Chip-Seq_HEK293_Human | 1.93404771 |
| 24 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.81433281 |
| 25 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.63265141 |
| 26 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.62349405 |
| 27 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.57409720 |
| 28 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.56925463 |
| 29 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.50415777 |
| 30 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.50248645 |
| 31 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.50047798 |
| 32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.45488601 |
| 33 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.45222644 |
| 34 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.44014079 |
| 35 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42777805 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41341404 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.40262878 |
| 38 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.39525702 |
| 39 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38778646 |
| 40 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.38492907 |
| 41 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.38250454 |
| 42 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.37461359 |
| 43 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.35525469 |
| 44 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.34338529 |
| 45 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.34234794 |
| 46 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.32474374 |
| 47 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.31171661 |
| 48 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.30229464 |
| 49 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.29333630 |
| 50 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.29327125 |
| 51 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.28625268 |
| 52 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.24362196 |
| 53 | FUS_26573619_Chip-Seq_HEK293_Human | 1.24008635 |
| 54 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.24001966 |
| 55 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.22774461 |
| 56 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.21087157 |
| 57 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.19619882 |
| 58 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.17613652 |
| 59 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.17401171 |
| 60 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.17273313 |
| 61 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.17109212 |
| 62 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.17109212 |
| 63 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.14606262 |
| 64 | P300_19829295_ChIP-Seq_ESCs_Human | 1.13800213 |
| 65 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13123564 |
| 66 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.10773556 |
| 67 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.10299123 |
| 68 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.09470202 |
| 69 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.08789454 |
| 70 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.07690785 |
| 71 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.07636286 |
| 72 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.07560962 |
| 73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.07465257 |
| 74 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.06799581 |
| 75 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.06586145 |
| 76 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.06533361 |
| 77 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.06225945 |
| 78 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.05922829 |
| 79 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05566659 |
| 80 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05564218 |
| 81 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.05131533 |
| 82 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04552181 |
| 83 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.03664092 |
| 84 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.03628487 |
| 85 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.03555730 |
| 86 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.03540738 |
| 87 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.03540738 |
| 88 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.03196660 |
| 89 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.03136603 |
| 90 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.01820134 |
| 91 | AR_20517297_ChIP-Seq_VCAP_Human | 1.01056546 |
| 92 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.00898596 |
| 93 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.00345823 |
| 94 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99431972 |
| 95 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.99322728 |
| 96 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.99316035 |
| 97 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.98804456 |
| 98 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98783316 |
| 99 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.98747944 |
| 100 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.97913772 |
| 101 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.97642195 |
| 102 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97346455 |
| 103 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.97240675 |
| 104 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.96949991 |
| 105 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.96903296 |
| 106 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.96033445 |
| 107 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.96007647 |
| 108 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.95554154 |
| 109 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.95444145 |
| 110 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.95054934 |
| 111 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.95019032 |
| 112 | AR_25329375_ChIP-Seq_VCAP_Human | 0.94754284 |
| 113 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.94553025 |
| 114 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.94051271 |
| 115 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.93324997 |
| 116 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.92676874 |
| 117 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.92588517 |
| 118 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.92518884 |
| 119 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.91336287 |
| 120 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.91239125 |
| 121 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.91093182 |
| 122 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.90812983 |
| 123 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.90637689 |
| 124 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.90493328 |
| 125 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.89881846 |
| 126 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.89798412 |
| 127 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.89152176 |
| 128 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.87493917 |
| 129 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.86930345 |
| 130 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.86537564 |
| 131 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.85217370 |
| 132 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.85217370 |
| 133 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.83499044 |
| 134 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.82668728 |
| 135 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.82668728 |
| 136 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.82058917 |
| 137 | NCOR_22424771_ChIP-Seq_293T_Human | 0.81948837 |
| 138 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.80131364 |
| 139 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.79882308 |
| 140 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.79080236 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.14078022 |
| 2 | MP0003646_muscle_fatigue | 4.40810194 |
| 3 | MP0000751_myopathy | 3.60307997 |
| 4 | MP0004215_abnormal_myocardial_fiber | 3.58221701 |
| 5 | MP0004084_abnormal_cardiac_muscle | 3.31813784 |
| 6 | MP0006036_abnormal_mitochondrial_physio | 3.24129494 |
| 7 | MP0003880_abnormal_central_pattern | 3.21146148 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.11332116 |
| 9 | MP0000749_muscle_degeneration | 3.05769848 |
| 10 | MP0001529_abnormal_vocalization | 2.89194151 |
| 11 | MP0005330_cardiomyopathy | 2.69194204 |
| 12 | MP0004145_abnormal_muscle_electrophysio | 2.44987105 |
| 13 | MP0006035_abnormal_mitochondrial_morpho | 2.26556989 |
| 14 | MP0006276_abnormal_autonomic_nervous | 2.20260899 |
| 15 | MP0002972_abnormal_cardiac_muscle | 2.18752543 |
| 16 | MP0009379_abnormal_foot_pigmentation | 2.17232046 |
| 17 | MP0004484_altered_response_of | 2.15367792 |
| 18 | MP0003137_abnormal_impulse_conducting | 2.11625211 |
| 19 | MP0005620_abnormal_muscle_contractility | 2.02458539 |
| 20 | MP0002332_abnormal_exercise_endurance | 1.88405606 |
| 21 | MP0001905_abnormal_dopamine_level | 1.82311848 |
| 22 | MP0004142_abnormal_muscle_tone | 1.76362889 |
| 23 | MP0008775_abnormal_heart_ventricle | 1.73055570 |
| 24 | MP0002106_abnormal_muscle_physiology | 1.70181647 |
| 25 | MP0004043_abnormal_pH_regulation | 1.66963306 |
| 26 | MP0002938_white_spotting | 1.66444863 |
| 27 | MP0002102_abnormal_ear_morphology | 1.64380170 |
| 28 | MP0004087_abnormal_muscle_fiber | 1.61421657 |
| 29 | MP0005379_endocrine/exocrine_gland_phen | 1.59621466 |
| 30 | MP0004085_abnormal_heartbeat | 1.58399911 |
| 31 | MP0001544_abnormal_cardiovascular_syste | 1.57086833 |
| 32 | MP0005385_cardiovascular_system_phenoty | 1.57086833 |
| 33 | MP0009046_muscle_twitch | 1.57006225 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.56528699 |
| 35 | MP0006138_congestive_heart_failure | 1.53441967 |
| 36 | MP0002234_abnormal_pharynx_morphology | 1.51716190 |
| 37 | MP0002736_abnormal_nociception_after | 1.49083307 |
| 38 | MP0003718_maternal_effect | 1.47765040 |
| 39 | MP0003806_abnormal_nucleotide_metabolis | 1.46174335 |
| 40 | MP0004130_abnormal_muscle_cell | 1.46116852 |
| 41 | MP0009745_abnormal_behavioral_response | 1.45390099 |
| 42 | MP0008058_abnormal_DNA_repair | 1.44255350 |
| 43 | MP0000750_abnormal_muscle_regeneration | 1.43346182 |
| 44 | MP0001968_abnormal_touch/_nociception | 1.42555185 |
| 45 | MP0005369_muscle_phenotype | 1.42423002 |
| 46 | MP0000747_muscle_weakness | 1.40217528 |
| 47 | MP0002064_seizures | 1.40086907 |
| 48 | MP0005253_abnormal_eye_physiology | 1.39854794 |
| 49 | MP0005408_hypopigmentation | 1.39766675 |
| 50 | MP0002272_abnormal_nervous_system | 1.39741566 |
| 51 | MP0008877_abnormal_DNA_methylation | 1.39155232 |
| 52 | MP0003122_maternal_imprinting | 1.37168669 |
| 53 | MP0001440_abnormal_grooming_behavior | 1.35475587 |
| 54 | MP0002822_catalepsy | 1.34609298 |
| 55 | MP0003195_calcinosis | 1.33454067 |
| 56 | MP0005386_behavior/neurological_phenoty | 1.30711699 |
| 57 | MP0004924_abnormal_behavior | 1.30711699 |
| 58 | MP0003221_abnormal_cardiomyocyte_apopto | 1.28292966 |
| 59 | MP0003011_delayed_dark_adaptation | 1.26870336 |
| 60 | MP0000631_abnormal_neuroendocrine_gland | 1.24805040 |
| 61 | MP0010030_abnormal_orbit_morphology | 1.24684248 |
| 62 | MP0004133_heterotaxia | 1.23370702 |
| 63 | MP0002127_abnormal_cardiovascular_syste | 1.23070430 |
| 64 | MP0002269_muscular_atrophy | 1.22819808 |
| 65 | MP0005171_absent_coat_pigmentation | 1.22634414 |
| 66 | MP0002090_abnormal_vision | 1.21815590 |
| 67 | MP0008789_abnormal_olfactory_epithelium | 1.19840026 |
| 68 | MP0000759_abnormal_skeletal_muscle | 1.17170699 |
| 69 | MP0002139_abnormal_hepatobiliary_system | 1.16718880 |
| 70 | MP0002638_abnormal_pupillary_reflex | 1.15867487 |
| 71 | MP0005266_abnormal_metabolism | 1.14869267 |
| 72 | MP0003635_abnormal_synaptic_transmissio | 1.10763566 |
| 73 | MP0003136_yellow_coat_color | 1.10477764 |
| 74 | MP0001984_abnormal_olfaction | 1.08927104 |
| 75 | MP0001346_abnormal_lacrimal_gland | 1.08910876 |
| 76 | MP0002735_abnormal_chemical_nociception | 1.08345708 |
| 77 | MP0009697_abnormal_copulation | 1.08252517 |
| 78 | MP0002572_abnormal_emotion/affect_behav | 1.07191579 |
| 79 | MP0003186_abnormal_redox_activity | 1.07076985 |
| 80 | MP0000230_abnormal_systemic_arterial | 1.06775512 |
| 81 | MP0005248_abnormal_Harderian_gland | 1.06694120 |
| 82 | MP0005332_abnormal_amino_acid | 1.06632287 |
| 83 | MP0005075_abnormal_melanosome_morpholog | 1.06340839 |
| 84 | MP0005535_abnormal_body_temperature | 1.05741553 |
| 85 | MP0004147_increased_porphyrin_level | 1.03815259 |
| 86 | MP0002734_abnormal_mechanical_nocicepti | 1.03192095 |
| 87 | MP0002095_abnormal_skin_pigmentation | 1.03108433 |
| 88 | MP0002067_abnormal_sensory_capabilities | 1.03092964 |
| 89 | MP0005451_abnormal_body_composition | 1.01874716 |
| 90 | MP0001486_abnormal_startle_reflex | 1.01609388 |
| 91 | MP0005165_increased_susceptibility_to | 0.97773104 |
| 92 | MP0008875_abnormal_xenobiotic_pharmacok | 0.97484143 |
| 93 | MP0005084_abnormal_gallbladder_morpholo | 0.97071789 |
| 94 | MP0002876_abnormal_thyroid_physiology | 0.96905372 |
| 95 | MP0010630_abnormal_cardiac_muscle | 0.96266814 |
| 96 | MP0005085_abnormal_gallbladder_physiolo | 0.96065448 |
| 97 | MP0001485_abnormal_pinna_reflex | 0.95293848 |
| 98 | MP0008004_abnormal_stomach_pH | 0.92677984 |
| 99 | MP0003890_abnormal_embryonic-extraembry | 0.91277042 |
| 100 | MP0008995_early_reproductive_senescence | 0.89623570 |
| 101 | MP0005423_abnormal_somatic_nervous | 0.89453973 |
| 102 | MP0001324_abnormal_eye_pigmentation | 0.89289572 |
| 103 | MP0005646_abnormal_pituitary_gland | 0.88928769 |
| 104 | MP0000013_abnormal_adipose_tissue | 0.88422902 |
| 105 | MP0002063_abnormal_learning/memory/cond | 0.88186740 |
| 106 | MP0003567_abnormal_fetal_cardiomyocyte | 0.88152182 |
| 107 | MP0001764_abnormal_homeostasis | 0.87394426 |
| 108 | MP0003787_abnormal_imprinting | 0.87020504 |
| 109 | MP0004957_abnormal_blastocyst_morpholog | 0.85956328 |
| 110 | MP0001970_abnormal_pain_threshold | 0.84468183 |
| 111 | MP0004233_abnormal_muscle_weight | 0.81434233 |
| 112 | MP0000647_abnormal_sebaceous_gland | 0.81386620 |
| 113 | MP0005360_urolithiasis | 0.79832826 |
| 114 | MP0004885_abnormal_endolymph | 0.78043374 |
| 115 | MP0005195_abnormal_posterior_eye | 0.77512635 |
| 116 | MP0005551_abnormal_eye_electrophysiolog | 0.77199040 |
| 117 | MP0002233_abnormal_nose_morphology | 0.76845861 |
| 118 | MP0004270_analgesia | 0.76745364 |
| 119 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76538105 |
| 120 | MP0005636_abnormal_mineral_homeostasis | 0.76460418 |
| 121 | MP0001501_abnormal_sleep_pattern | 0.75930455 |
| 122 | MP0003941_abnormal_skin_development | 0.75690622 |
| 123 | MP0003828_pulmonary_edema | 0.75038732 |
| 124 | MP0004510_myositis | 0.73042424 |
| 125 | MP0002163_abnormal_gland_morphology | 0.72665871 |
| 126 | MP0001727_abnormal_embryo_implantation | 0.71713117 |
| 127 | MP0005376_homeostasis/metabolism_phenot | 0.71257709 |
| 128 | MP0001661_extended_life_span | 0.71161654 |
| 129 | MP0006072_abnormal_retinal_apoptosis | 0.69851540 |
| 130 | MP0002210_abnormal_sex_determination | 0.69777260 |
| 131 | MP0005499_abnormal_olfactory_system | 0.69276673 |
| 132 | MP0005394_taste/olfaction_phenotype | 0.69276673 |
| 133 | MP0000372_irregular_coat_pigmentation | 0.68666659 |
| 134 | MP0008872_abnormal_physiological_respon | 0.67843713 |
| 135 | MP0002066_abnormal_motor_capabilities/c | 0.67475475 |
| 136 | MP0005645_abnormal_hypothalamus_physiol | 0.66570969 |
| 137 | MP0010386_abnormal_urinary_bladder | 0.65183674 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 7.56523355 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 7.08283875 |
| 3 | Mitochondrial inheritance (HP:0001427) | 6.47100421 |
| 4 | Progressive macrocephaly (HP:0004481) | 6.45477573 |
| 5 | Acute encephalopathy (HP:0006846) | 6.43687758 |
| 6 | Hepatocellular necrosis (HP:0001404) | 5.77981533 |
| 7 | Increased CSF lactate (HP:0002490) | 5.74754039 |
| 8 | Hepatic necrosis (HP:0002605) | 5.53441953 |
| 9 | Cerebral edema (HP:0002181) | 4.99012353 |
| 10 | Increased hepatocellular lipid droplets (HP:0006565) | 4.53499954 |
| 11 | Abnormality of glycolysis (HP:0004366) | 4.38729522 |
| 12 | Increased serum pyruvate (HP:0003542) | 4.38729522 |
| 13 | Lipid accumulation in hepatocytes (HP:0006561) | 4.34208535 |
| 14 | Exercise intolerance (HP:0003546) | 4.25049210 |
| 15 | Respiratory failure (HP:0002878) | 4.19813122 |
| 16 | Lactic acidosis (HP:0003128) | 4.18590011 |
| 17 | Increased intramyocellular lipid droplets (HP:0012240) | 4.10171357 |
| 18 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.85578607 |
| 19 | Calf muscle hypertrophy (HP:0008981) | 3.84831231 |
| 20 | Increased muscle lipid content (HP:0009058) | 3.84480864 |
| 21 | Optic disc pallor (HP:0000543) | 3.83995732 |
| 22 | Sudden death (HP:0001699) | 3.79809768 |
| 23 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.76155593 |
| 24 | Leukodystrophy (HP:0002415) | 3.68162877 |
| 25 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.66903667 |
| 26 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.66903667 |
| 27 | Increased serum lactate (HP:0002151) | 3.61283440 |
| 28 | Renal Fanconi syndrome (HP:0001994) | 3.60698305 |
| 29 | Pheochromocytoma (HP:0002666) | 3.39332111 |
| 30 | Neuroendocrine neoplasm (HP:0100634) | 3.36407003 |
| 31 | Exercise-induced myalgia (HP:0003738) | 3.36033964 |
| 32 | Exercise-induced muscle cramps (HP:0003710) | 3.17206319 |
| 33 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.14606047 |
| 34 | 3-Methylglutaconic aciduria (HP:0003535) | 3.09911398 |
| 35 | Palpitations (HP:0001962) | 2.99642137 |
| 36 | Ventricular tachycardia (HP:0004756) | 2.92175136 |
| 37 | Myoglobinuria (HP:0002913) | 2.87641869 |
| 38 | Lethargy (HP:0001254) | 2.84136567 |
| 39 | Abnormality of the calf musculature (HP:0001430) | 2.81458497 |
| 40 | CNS demyelination (HP:0007305) | 2.75965166 |
| 41 | Respiratory difficulties (HP:0002880) | 2.69519040 |
| 42 | Atrial fibrillation (HP:0005110) | 2.68036744 |
| 43 | Exertional dyspnea (HP:0002875) | 2.64889953 |
| 44 | Conjunctival hamartoma (HP:0100780) | 2.62879998 |
| 45 | Rhabdomyolysis (HP:0003201) | 2.59751393 |
| 46 | True hermaphroditism (HP:0010459) | 2.57135147 |
| 47 | Congenital, generalized hypertrichosis (HP:0004540) | 2.56155756 |
| 48 | Abnormality of urine glucose concentration (HP:0011016) | 2.54463492 |
| 49 | Glycosuria (HP:0003076) | 2.54463492 |
| 50 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.51975280 |
| 51 | Dicarboxylic aciduria (HP:0003215) | 2.51975280 |
| 52 | Supraventricular tachycardia (HP:0004755) | 2.51511333 |
| 53 | Primary atrial arrhythmia (HP:0001692) | 2.51299759 |
| 54 | Abnormality of alanine metabolism (HP:0010916) | 2.49674579 |
| 55 | Hyperalaninemia (HP:0003348) | 2.49674579 |
| 56 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.49674579 |
| 57 | Syncope (HP:0001279) | 2.47093690 |
| 58 | X-linked dominant inheritance (HP:0001423) | 2.44778481 |
| 59 | Supraventricular arrhythmia (HP:0005115) | 2.42127449 |
| 60 | Pancreatic cysts (HP:0001737) | 2.42032235 |
| 61 | Macrocytic anemia (HP:0001972) | 2.41175884 |
| 62 | Pancreatic fibrosis (HP:0100732) | 2.40588061 |
| 63 | Molar tooth sign on MRI (HP:0002419) | 2.40203180 |
| 64 | Abnormality of midbrain morphology (HP:0002418) | 2.40203180 |
| 65 | Lipoatrophy (HP:0100578) | 2.40052860 |
| 66 | Muscle fiber splitting (HP:0003555) | 2.38367949 |
| 67 | Abnormality of renal resorption (HP:0011038) | 2.37759485 |
| 68 | Emotional lability (HP:0000712) | 2.35067312 |
| 69 | Focal motor seizures (HP:0011153) | 2.30230040 |
| 70 | Prolonged QT interval (HP:0001657) | 2.29468359 |
| 71 | Abnormal number of erythroid precursors (HP:0012131) | 2.28946041 |
| 72 | Abnormality of methionine metabolism (HP:0010901) | 2.27911956 |
| 73 | Ragged-red muscle fibers (HP:0003200) | 2.26690986 |
| 74 | Medial flaring of the eyebrow (HP:0010747) | 2.25184866 |
| 75 | Methylmalonic aciduria (HP:0012120) | 2.23270564 |
| 76 | Dilated cardiomyopathy (HP:0001644) | 2.22537362 |
| 77 | Type I transferrin isoform profile (HP:0003642) | 2.22120423 |
| 78 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.21722477 |
| 79 | Vomiting (HP:0002013) | 2.15360411 |
| 80 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.14942950 |
| 81 | Ketoacidosis (HP:0001993) | 2.11738763 |
| 82 | Muscle stiffness (HP:0003552) | 2.11262044 |
| 83 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.11136802 |
| 84 | Myotonia (HP:0002486) | 2.07287974 |
| 85 | EMG: myopathic abnormalities (HP:0003458) | 2.04968158 |
| 86 | Renal cortical cysts (HP:0000803) | 2.04934598 |
| 87 | Nephronophthisis (HP:0000090) | 2.04442092 |
| 88 | Methylmalonic acidemia (HP:0002912) | 2.02479563 |
| 89 | Colon cancer (HP:0003003) | 2.02078575 |
| 90 | Left ventricular hypertrophy (HP:0001712) | 2.01117592 |
| 91 | Gliosis (HP:0002171) | 2.00090753 |
| 92 | Hyperphosphaturia (HP:0003109) | 1.99855391 |
| 93 | Ventricular fibrillation (HP:0001663) | 1.98740002 |
| 94 | Esophageal neoplasm (HP:0100751) | 1.95031242 |
| 95 | Neoplasm of head and neck (HP:0012288) | 1.95031242 |
| 96 | Hyperglycinemia (HP:0002154) | 1.94704923 |
| 97 | Reticulocytopenia (HP:0001896) | 1.94478744 |
| 98 | Generalized aminoaciduria (HP:0002909) | 1.92975981 |
| 99 | Degeneration of anterior horn cells (HP:0002398) | 1.89177211 |
| 100 | Abnormality of the anterior horn cell (HP:0006802) | 1.89177211 |
| 101 | Sclerocornea (HP:0000647) | 1.88635008 |
| 102 | Hypoglycemic coma (HP:0001325) | 1.87199587 |
| 103 | Metabolic acidosis (HP:0001942) | 1.85659055 |
| 104 | Hyperglycinuria (HP:0003108) | 1.85239003 |
| 105 | Abnormality of serum amino acid levels (HP:0003112) | 1.84565719 |
| 106 | Cerebral hemorrhage (HP:0001342) | 1.83665457 |
| 107 | Ventricular arrhythmia (HP:0004308) | 1.83647336 |
| 108 | Ketosis (HP:0001946) | 1.82745928 |
| 109 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.82273047 |
| 110 | Male pseudohermaphroditism (HP:0000037) | 1.80926561 |
| 111 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.80884907 |
| 112 | Muscle fiber inclusion bodies (HP:0100299) | 1.80641850 |
| 113 | Abnormal protein glycosylation (HP:0012346) | 1.80316694 |
| 114 | Abnormal glycosylation (HP:0012345) | 1.80316694 |
| 115 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.80316694 |
| 116 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.80316694 |
| 117 | Myokymia (HP:0002411) | 1.79551460 |
| 118 | Abnormal EKG (HP:0003115) | 1.79113000 |
| 119 | Esophageal atresia (HP:0002032) | 1.78247743 |
| 120 | Progressive external ophthalmoplegia (HP:0000590) | 1.77410884 |
| 121 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.76497674 |
| 122 | Abnormality of the renal cortex (HP:0011035) | 1.76348291 |
| 123 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.75519002 |
| 124 | Gait imbalance (HP:0002141) | 1.75125633 |
| 125 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.74952253 |
| 126 | Abnormal ciliary motility (HP:0012262) | 1.74489038 |
| 127 | Microvesicular hepatic steatosis (HP:0001414) | 1.73994421 |
| 128 | Congenital primary aphakia (HP:0007707) | 1.73599491 |
| 129 | Abnormality of the labia minora (HP:0012880) | 1.71961350 |
| 130 | Hypoplastic left heart (HP:0004383) | 1.70452739 |
| 131 | Reduced antithrombin III activity (HP:0001976) | 1.70436205 |
| 132 | Abnormality of vitamin B metabolism (HP:0004340) | 1.70194360 |
| 133 | Hypoplasia of the fovea (HP:0007750) | 1.70043843 |
| 134 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.70043843 |
| 135 | Hyperammonemia (HP:0001987) | 1.69908146 |
| 136 | Neoplasm of the adrenal gland (HP:0100631) | 1.69800953 |
| 137 | Nemaline bodies (HP:0003798) | 1.69787737 |
| 138 | Stenosis of the external auditory canal (HP:0000402) | 1.69575329 |
| 139 | Hyperventilation (HP:0002883) | 1.69389217 |
| 140 | Blindness (HP:0000618) | 1.68925043 |
| 141 | Hyporeflexia of lower limbs (HP:0002600) | 1.66965944 |
| 142 | Abnormality of the fovea (HP:0000493) | 1.66857032 |
| 143 | Rimmed vacuoles (HP:0003805) | 1.66390143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 3.87314812 |
| 2 | NME1 | 3.72627926 |
| 3 | MYLK | 3.67544189 |
| 4 | MAP3K12 | 3.21203816 |
| 5 | VRK2 | 3.09196399 |
| 6 | PDK3 | 2.79493194 |
| 7 | PDK4 | 2.79493194 |
| 8 | BCKDK | 2.62738687 |
| 9 | TAOK2 | 2.59545128 |
| 10 | STK39 | 2.51052180 |
| 11 | NME2 | 2.47305783 |
| 12 | STK16 | 2.42123085 |
| 13 | GRK7 | 2.36888199 |
| 14 | FRK | 2.33409755 |
| 15 | PHKG2 | 2.25108475 |
| 16 | PHKG1 | 2.25108475 |
| 17 | MAP4K2 | 2.22229669 |
| 18 | WNK4 | 2.15028899 |
| 19 | ACVR1B | 2.08674823 |
| 20 | MUSK | 1.95505789 |
| 21 | CASK | 1.90407473 |
| 22 | PDK2 | 1.89018014 |
| 23 | ARAF | 1.86516457 |
| 24 | OXSR1 | 1.83812723 |
| 25 | LMTK2 | 1.83126218 |
| 26 | MST4 | 1.80414813 |
| 27 | CDK19 | 1.73772683 |
| 28 | PBK | 1.65749256 |
| 29 | MAP2K7 | 1.60257134 |
| 30 | NUAK1 | 1.56323599 |
| 31 | TTN | 1.55709331 |
| 32 | PINK1 | 1.51281295 |
| 33 | ERBB3 | 1.48762163 |
| 34 | STK24 | 1.42580826 |
| 35 | TLK1 | 1.33557399 |
| 36 | BCR | 1.32998512 |
| 37 | CAMK2D | 1.25998181 |
| 38 | TIE1 | 1.25642274 |
| 39 | TRIM28 | 1.24749019 |
| 40 | PLK3 | 1.24668544 |
| 41 | GRK5 | 1.22324122 |
| 42 | PNCK | 1.20361844 |
| 43 | MAP3K4 | 1.19951277 |
| 44 | CSNK1G2 | 1.13264422 |
| 45 | TAF1 | 1.13245674 |
| 46 | MAP2K4 | 1.11263277 |
| 47 | ADRBK2 | 1.10024070 |
| 48 | CSNK1G1 | 1.09085620 |
| 49 | CAMK2A | 1.08750598 |
| 50 | TTK | 1.06282066 |
| 51 | ILK | 1.06070162 |
| 52 | LIMK1 | 1.02683535 |
| 53 | BUB1 | 1.02482162 |
| 54 | CAMK2G | 0.98244713 |
| 55 | NEK1 | 0.96815964 |
| 56 | PIK3CA | 0.96745952 |
| 57 | BRAF | 0.95765717 |
| 58 | VRK1 | 0.94320998 |
| 59 | CAMK2B | 0.90592376 |
| 60 | DAPK3 | 0.90096194 |
| 61 | CSNK1A1L | 0.89419708 |
| 62 | PLK2 | 0.88666363 |
| 63 | WNK3 | 0.86995848 |
| 64 | FGFR2 | 0.85486722 |
| 65 | ADRBK1 | 0.85011362 |
| 66 | EIF2AK1 | 0.82263220 |
| 67 | PKN1 | 0.82118153 |
| 68 | STK38L | 0.81380681 |
| 69 | ZAK | 0.79980986 |
| 70 | TNIK | 0.79079792 |
| 71 | PLK4 | 0.78529506 |
| 72 | PIK3CG | 0.78361842 |
| 73 | EPHA4 | 0.75158142 |
| 74 | BRSK2 | 0.72711667 |
| 75 | PRKCE | 0.72455141 |
| 76 | TGFBR1 | 0.71648746 |
| 77 | BMPR2 | 0.71215267 |
| 78 | PLK1 | 0.68781560 |
| 79 | PRKACA | 0.68439706 |
| 80 | ABL2 | 0.68124631 |
| 81 | ROCK2 | 0.68069449 |
| 82 | CCNB1 | 0.67919904 |
| 83 | NTRK3 | 0.66336960 |
| 84 | PAK3 | 0.65411295 |
| 85 | MAPKAPK3 | 0.64786664 |
| 86 | MAPK12 | 0.64627660 |
| 87 | PRPF4B | 0.62333781 |
| 88 | BMPR1B | 0.60961808 |
| 89 | UHMK1 | 0.60174429 |
| 90 | MST1R | 0.59410998 |
| 91 | MAPK13 | 0.58003566 |
| 92 | MKNK1 | 0.56394953 |
| 93 | PRKCG | 0.56022731 |
| 94 | EIF2AK3 | 0.55906654 |
| 95 | MINK1 | 0.52982276 |
| 96 | EIF2AK2 | 0.52925313 |
| 97 | PTK2B | 0.51204463 |
| 98 | MAP3K11 | 0.50862850 |
| 99 | MAP2K6 | 0.47158037 |
| 100 | CAMKK2 | 0.45025652 |
| 101 | CSNK2A2 | 0.44575309 |
| 102 | MAPKAPK5 | 0.44427749 |
| 103 | NTRK2 | 0.44320194 |
| 104 | RPS6KB2 | 0.42652415 |
| 105 | ROCK1 | 0.42111868 |
| 106 | AURKB | 0.41270615 |
| 107 | CDC7 | 0.40038746 |
| 108 | MAP3K5 | 0.40009167 |
| 109 | MARK1 | 0.39813028 |
| 110 | DYRK2 | 0.39133609 |
| 111 | TSSK6 | 0.38011301 |
| 112 | WEE1 | 0.37188765 |
| 113 | CSNK1A1 | 0.37093486 |
| 114 | CHEK2 | 0.36878421 |
| 115 | INSRR | 0.36531620 |
| 116 | PASK | 0.36436274 |
| 117 | IRAK2 | 0.35692673 |
| 118 | CDK8 | 0.35312325 |
| 119 | PRKCQ | 0.35184598 |
| 120 | PRKACB | 0.35060918 |
| 121 | KDR | 0.34401016 |
| 122 | BRSK1 | 0.34311271 |
| 123 | PRKG1 | 0.32363596 |
| 124 | WNK1 | 0.30599212 |
| 125 | CSNK1G3 | 0.30337246 |
| 126 | CSNK2A1 | 0.30001600 |
| 127 | DAPK1 | 0.29352044 |
| 128 | CAMK1 | 0.28252260 |
| 129 | SRPK1 | 0.27976761 |
| 130 | PRKCA | 0.27952661 |
| 131 | GRK1 | 0.27022375 |
| 132 | PRKACG | 0.26691557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 6.36142919 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 5.57067504 |
| 3 | Alzheimers disease_Homo sapiens_hsa05010 | 4.13505726 |
| 4 | Huntingtons disease_Homo sapiens_hsa05016 | 3.89415670 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.88335492 |
| 6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.55644766 |
| 7 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 3.50105181 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.52840415 |
| 9 | Ribosome_Homo sapiens_hsa03010 | 2.43725360 |
| 10 | Proteasome_Homo sapiens_hsa03050 | 2.37770574 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.23567513 |
| 12 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.03078791 |
| 13 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.02531698 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.02310722 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.73577987 |
| 16 | Carbon metabolism_Homo sapiens_hsa01200 | 1.72567484 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.65882884 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.63893941 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.60966736 |
| 20 | Protein export_Homo sapiens_hsa03060 | 1.58729425 |
| 21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55045716 |
| 22 | Homologous recombination_Homo sapiens_hsa03440 | 1.53092569 |
| 23 | Mismatch repair_Homo sapiens_hsa03430 | 1.50134604 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.48978102 |
| 25 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.39325848 |
| 26 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.28190606 |
| 27 | RNA polymerase_Homo sapiens_hsa03020 | 1.27134518 |
| 28 | Basal transcription factors_Homo sapiens_hsa03022 | 1.25185323 |
| 29 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.18199614 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.16895418 |
| 31 | RNA degradation_Homo sapiens_hsa03018 | 1.14604286 |
| 32 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.10671763 |
| 33 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.03098670 |
| 34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.99471876 |
| 35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.99189960 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.97502784 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.96680064 |
| 38 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.95821222 |
| 39 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.95529518 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 0.91809430 |
| 41 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.90030163 |
| 42 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.89801977 |
| 43 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.89783585 |
| 44 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.85159902 |
| 45 | Nicotine addiction_Homo sapiens_hsa05033 | 0.84792060 |
| 46 | DNA replication_Homo sapiens_hsa03030 | 0.83617025 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.79519145 |
| 48 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.77034145 |
| 49 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.75820062 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.74485375 |
| 51 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.72207322 |
| 52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.71924203 |
| 53 | RNA transport_Homo sapiens_hsa03013 | 0.71231877 |
| 54 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.65644613 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64893342 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61092691 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60901978 |
| 58 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.60122323 |
| 59 | Spliceosome_Homo sapiens_hsa03040 | 0.58398917 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58067819 |
| 61 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.57942192 |
| 62 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57309669 |
| 63 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.57192231 |
| 64 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.57095651 |
| 65 | Base excision repair_Homo sapiens_hsa03410 | 0.55627372 |
| 66 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.55017773 |
| 67 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.54067136 |
| 68 | GABAergic synapse_Homo sapiens_hsa04727 | 0.53420529 |
| 69 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.53115768 |
| 70 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.53002362 |
| 71 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.52643557 |
| 72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.51209616 |
| 73 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.51001864 |
| 74 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.50262057 |
| 75 | Purine metabolism_Homo sapiens_hsa00230 | 0.49583456 |
| 76 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49303692 |
| 77 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.48794699 |
| 78 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.46999181 |
| 79 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.45346606 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.43911822 |
| 81 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.43514496 |
| 82 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.43364747 |
| 83 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.41968865 |
| 84 | Taste transduction_Homo sapiens_hsa04742 | 0.41429795 |
| 85 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.40683194 |
| 86 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.38383842 |
| 87 | Morphine addiction_Homo sapiens_hsa05032 | 0.38002228 |
| 88 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.37966452 |
| 89 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37296021 |
| 90 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.36888255 |
| 91 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.36199040 |
| 92 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.36084001 |
| 93 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.35620852 |
| 94 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.35239448 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31096183 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.31024178 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30946575 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30816251 |
| 99 | Phototransduction_Homo sapiens_hsa04744 | 0.29894229 |
| 100 | Asthma_Homo sapiens_hsa05310 | 0.27836890 |
| 101 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.27189628 |
| 102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.26928016 |
| 103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26914849 |
| 104 | Circadian entrainment_Homo sapiens_hsa04713 | 0.26808727 |
| 105 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.25955992 |
| 106 | Histidine metabolism_Homo sapiens_hsa00340 | 0.25254938 |
| 107 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.24476881 |
| 108 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.20352144 |
| 109 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.19559761 |
| 110 | Sulfur relay system_Homo sapiens_hsa04122 | 0.19506850 |
| 111 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.18952933 |
| 112 | Olfactory transduction_Homo sapiens_hsa04740 | 0.17629783 |
| 113 | Renin secretion_Homo sapiens_hsa04924 | 0.17595480 |
| 114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.17063135 |
| 115 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.16854805 |
| 116 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.15977419 |
| 117 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.15903988 |
| 118 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.15694271 |
| 119 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14397455 |
| 120 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.14008432 |
| 121 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.12490707 |
| 122 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.12367442 |
| 123 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.11274295 |
| 124 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.11137833 |
| 125 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.10816524 |
| 126 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.10669512 |
| 127 | Insulin secretion_Homo sapiens_hsa04911 | 0.10475563 |
| 128 | Retinol metabolism_Homo sapiens_hsa00830 | 0.10383207 |
| 129 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.08569069 |

